US Patent Issued to Principia Biopharma on May 12 for "4-amino-3-(4-phenoxyphenyl)-1,3-dihydro-2H-imidazo[4,5-cpyridin-2-one derivatives and salts thereof" (French Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,030, issued on May 12, was assigned to Principia Biopharma Inc. (Morristown, N.J.).

"4-amino-3-(4-phenoxyphenyl)-1,3-dihydro-2H-imidazo[4,5-cpyridin-2-one derivatives and salts thereof" was invented by Catherine Arabeyre (Prades le Lez, France), Patricia Moliner (Perols, France), Sabine Boisnard (Boulogne, France), Damien Sallaberry (Le Plessis Robinson, France), Serge Perard (Palaiseau, France) and Sebastien Roy (Sermaise, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to 4-amino-3-(4-phenoxyphenyl)-1,3-dihydro-2H-imidazo[4,5-c]pyridin-2-one variants or derivatives, and salts thereof, for use as agonists and ant...